A phase II trial of postoperative radiotherapy (RT), cisplatin, and panitumumab in patients with high-risk, resected locally advanced squamous cell carcinoma of the head and neck (SCCHN).
2010 ◽
Vol 28
(15_suppl)
◽
pp. TPS262-TPS262
◽
2010 ◽
Vol 28
(15_suppl)
◽
pp. 5580-5580
◽
2005 ◽
Vol 93
(10)
◽
pp. 1117-1121
◽
2003 ◽
Vol 1
(5)
◽
pp. S48-S49